BCG-refractory vs. BCG-relapsing non–muscle-invasive bladder cancer: A prospective cohort outcomes study
Author:
Publisher
Elsevier BV
Subject
Urology,Oncology
Reference6 articles.
1. Defining BCG refractory superficial bladder tumors;Herr;J Urol,2003
2. Do prognostic parameters of remission versus relapse after BCG immunotherapy exist? Analysis of a quarter century of literature;Saint;Eur Urol,2003
3. Management of BCG failures in superficial bladder cancer: a review;Witjes;Eur Urol,2006
4. Efficacy and safety of mycobacterial cell wall DNA complex in the treatment of patients with non-muscle invasive bladder cancer at high risk of progression who are refractory to BCG;Morales;J Urol,2011
5. Intravesical gemcitabine for high risk, nonmuscle invasive bladder cancer after Bacillus Calmette-Guérin treatment failure;Sternberg;J Urol,2013
Cited by 47 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Editorial Comment on “Low-grade Urothelial Carcinoma Recurs at a Tempo That Naturally Accelerates Over Time”;Urology;2024-08
2. European Association of Urology Guidelines on Non–muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ)—A Summary of the 2024 Guidelines Update;European Urology;2024-08
3. Urinary comprehensive genomic profiling predicts urothelial carcinoma recurrence and identifies responders to intravesical therapy;Molecular Oncology;2023-10-05
4. Conservative treatment for high-risk NMIBC failing BCG treatment: who benefits from adding electromotive drug administration (EMDA) of mitomycin C (MMC) to a second BCG induction cycle?;World Journal of Urology;2023-03-27
5. Can we offer additional BCG therapy for three-month BCG refractory high grade/T1, Tis bladder cancer patients?;Arab Journal of Urology;2023-03-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3